Periodic Reporting for period 2 - SIME-LMT (Development of a digital diagnostics rapid Lung Maturity Test (LMT) for premature infants, to assist neonatologists in the diagnosis of Respiratory Distress Syndrome at birth)
Reporting period: 2016-04-01 to 2017-03-31
1. To further validate the LMT method and publish observational study data
2. Build product prototypes and conduct user-testing
3. Develop a cloud infrastructure model to deliver Software as a Service (SaaS)
4. Conduct a clinical trial to measure the impact of the SIME LMT on clinical outcomes
During the second year of the project, SIME have further refined and validated the LMT method and generated new IP for which we are applying for patent protection. We have published our most recent observational study in Acta Paediatrica, a leading journal. We are refining our LMT prototype, including the device itself. In collaboration with Microsoft, we have architected the database using next generation Microsoft Azure components and are integrating this configuration to the user interface. We have also continued our extensive dissemination and have refined our strategy for market research and commercialisation. Finally, we have recruited research partners and commenced an observational clinical trial in Denmark. The aim of this trial is to measure the effect of the LMT test and early treatment on key clinical outcomes.